Protein synthesis in muscle measured in vivo in cachectic patients with cancer
- PMID: 6087973
- PMCID: PMC1442890
- DOI: 10.1136/bmj.289.6445.584
Protein synthesis in muscle measured in vivo in cachectic patients with cancer
Abstract
Rates of synthesis of protein were measured in vivo in skeletal muscle and in the whole body of cachectic patients with cancer and in normal healthy men, using a tracer infusion of leucine labelled with a stable isotope. Synthesis of protein in muscle was significantly reduced in the patients with cancer (0.030 v 0.198%/hour; p less than 0.01), whereas whole body rates of protein synthesis and degradation did not differ significantly between the two groups. Thus depression of synthesis of protein in muscle appeared to be the immediate cause of muscle wasting in cancerous cachexia. Any therapeutic intervention that aims at preventing the onset of cachexia should be designed to stimulate the synthesis of protein in muscle, and measurement of turnover of protein may be used to evaluate such treatment provided that rates of protein synthesis are measured directly in specific tissues.
Similar articles
-
Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover.Cancer. 1998 Jan 1;82(1):42-8. Cancer. 1998. PMID: 9428478
-
Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia.Clin Nutr. 2012 Oct;31(5):765-73. doi: 10.1016/j.clnu.2012.05.003. Epub 2012 May 29. Clin Nutr. 2012. PMID: 22647419
-
Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Oxid Med Cell Longev. 2017;2017:8018197. doi: 10.1155/2017/8018197. Epub 2017 Dec 11. Oxid Med Cell Longev. 2017. PMID: 29375734 Free PMC article. Review.
-
Protein synthesis measured in vivo in muscle and liver of cachectic tumor-bearing mice.Cancer Res. 1984 Jul;44(7):2779-84. Cancer Res. 1984. PMID: 6722806
-
Mechanisms to explain wasting of muscle and fat in cancer cachexia.Curr Opin Support Palliat Care. 2007 Dec;1(4):293-8. doi: 10.1097/SPC.0b013e3282f34738. Curr Opin Support Palliat Care. 2007. PMID: 18685378 Review.
Cited by
-
Advancing cancer cachexia diagnosis with -omics technology and exercise as molecular medicine.Sports Med Health Sci. 2024 Jan 28;6(1):1-15. doi: 10.1016/j.smhs.2024.01.006. eCollection 2024 Mar. Sports Med Health Sci. 2024. PMID: 38463663 Free PMC article. Review.
-
Transcriptional programming of translation by BCL6 controls skeletal muscle proteostasis.Nat Metab. 2024 Feb;6(2):304-322. doi: 10.1038/s42255-024-00983-3. Epub 2024 Feb 9. Nat Metab. 2024. PMID: 38337096 Free PMC article.
-
Molecular Mechanisms of Cachexia: A Review.Cells. 2024 Jan 29;13(3):252. doi: 10.3390/cells13030252. Cells. 2024. PMID: 38334644 Free PMC article. Review.
-
Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies.J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1150-1167. doi: 10.1002/jcsm.13073. Epub 2023 Mar 2. J Cachexia Sarcopenia Muscle. 2023. PMID: 36864755 Free PMC article. Review.
-
LP07 and LLC preclinical models of lung cancer induce divergent anabolic deficits and expression of pro-inflammatory effectors of muscle wasting.J Appl Physiol (1985). 2022 Dec 1;133(6):1260-1272. doi: 10.1152/japplphysiol.00246.2022. Epub 2022 Oct 6. J Appl Physiol (1985). 2022. PMID: 36201324 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources